Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Follow-Up and Monitoring

A plan for follow-up and monitoring to determine whether the goals have been achieved and adverse effects avoided... [Pg.1017]

Walsh M Department of Veterans Affairs Medical Center, Boston MA Follow-up and monitoring of gulf war veterans with fragments of depleted uranium and other sources of depleted uranium. Department of Veterans Affairs Research and Development... [Pg.248]

Steroid receptors in tissue predicting response to hormone therapy CEA and one MUCl-gene-related protein in serum for prognosis, follow-up, and monitoring of therapy... [Pg.752]

Distribution software has had many years to evolve and improve. Software that supports the provision of pharmaceutical care is still maturing. The provision of pharmaceutical care is a process. Whether this provision occurs in a community, health system, long-term care facility, or other pharmacy practice setting, there is a process that underlies each practice. The practice of pharmaceutical care begins with the appraisal of the patient. Based on the findings of that appraisal, the pharmacist will perform one or several interventions. Having documented an intervention, the pharmacist will then need to evaluate the outcomes of these interventions. Once the desired outcomes have been achieved and documented, a suitable follow-up and monitoring schedule should be established. [Pg.221]

Arrange Schedule follow-up and monitor for continued abstinence. [Pg.544]

TRH test unreliable in the follow-up and monitoring of antithyroid therapy for a period of up to 4 months after clinical remission has occurred. [Pg.182]

Optimal patient safety requires that the physicians, surgeons and patient be able to recognize complications or deviations for expected outcomes early and take action to minimize the efiect on patient outcomes [31]. Continual assessment for threats to patient safety and prevention of serious adverse outcomes is the goal. Optimization of patient outcomes is more likely if responsible physicians and nurses establish a system of careful follow-up and monitoring. Following operative placement of a PD catheter, the most common complications are infection and malfunctioning of the catheter. [Pg.194]

Hazard Evaluation Hazard, Plant, Process, Equipment, Process Variables, Position, Cause, Consequence, Initial-Event (Root Cause) Develop/generate by safety experts/engineers/auditors Follow-up and monitor by CAPE-SAFE and safety experts/engineers/auditors... [Pg.128]

Few papers have looked at the economic implications of bipolar affective disorder. Most of the published studies look at direct medical costs over the course of a year. Industry-sponsored studies focus on the benefits of a new treatment over older treatments. However, factors individual to a particular patient are likely to be more important than the average cost of a particular treatment. These include selection of patients who are likely to respond to a particular treatment, and psychoeducation coupled with encouragement during follow-up and carefial monitoring, to avoid such expensive outcomes as ftill-blown relapse, serious toxicity or suicide. [Pg.75]

Watchful waiting and safety-net antibiotic prescriptions are approaches being used more frequently to attenuate microbial resistance and avoid unnecessary adverse events and costs of antibiotics. Observation is practiced extensively in Europe and involves monitoring for 48 to 72 hours after diagnosing AOM to see if spontaneous resolution will occur. Observation or delayed antibiotic therapy should be considered only in otherwise healthy children without recurrent disease (Fig. 69-1) and only if proper follow-up and good communication exist between clinicians and the parent/caregiver.4,5,16... [Pg.1064]

Failure of any of these three components may eventually result in a repeat incident. A system to follow-up and track each recommendation or resolution until completion must be in place. The investigation should produce a work product that facilitates prediction of the results of recommended changes that are observable and capable of being monitored because they are observable. Figure 13-1 presents an overview of the activities recommended in this chapter. [Pg.306]

An action level in microbiological environmental monitoring is the level of microorganisms that, when exceeded, requires immediate follow-up and, if necessary, corrective action. The evaluation does not depend on the number of colonies only but also on the types of microbes isolated and the suspected hazard. [Pg.744]

The composition of DMCs is typically multidisciplinary, and the participation of both clinicians and statisticians is critical. The DMC for a particular trial can be appointed by the trial sponsor or by a steering committee. Its duties can include reviewing the initial protocol, monitoring the conduct of the study by assessing accrual, eligibility, protocol compliance, losses to follow-up, and other issues concerned with safeguarding the subjects and the integrity of the trial. [Pg.181]

Assessment of its benefit to harm balance does not support the use of felbamate in new-onset epilepsy in children and adults, in patients who have significant prior hematological adverse events, in patients in whom follow-up and comph-ance will not allow careful monitoring, and in patients who are unable to discuss risk/benefits and for whom no parent or legal guardian is available to provide consent... [Pg.1328]

Pharmacists can play an important role in the multidisciplinary team management of heart failure. Compared with conventional treatment, pharmacist intervention that included medication evaluation and therapeutic recommendations, patient education, and follow-up telephone monitoring reduced hospitalizations for heart failure. Adherence to guideline-recommended therapy was improved by pharmacist intervention. Thus the role and cost benefits of pharmacist involvement in the multidisciplinary care of heart failure... [Pg.255]

Niu C, Yan H, Yu T, et al. Studies of treatment of acute promyelocytic leukemia with arsenic trioxide remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 1999 94 3315-3324. [Pg.2510]

The use of human subjects for test purposes, including studies on prisoners once widely used, has happily essentially disappeared. It has not, however, been adequately replaced by careful study of individuals who have already been exposed to toxic agents thus the wider use of clinical follow-up and biological monitoring is an urgent need in this issue of transfer of information from the test species to man. [Pg.16]


See other pages where Follow-Up and Monitoring is mentioned: [Pg.437]    [Pg.142]    [Pg.1]    [Pg.51]    [Pg.753]    [Pg.753]    [Pg.40]    [Pg.65]    [Pg.178]    [Pg.96]    [Pg.96]    [Pg.437]    [Pg.142]    [Pg.1]    [Pg.51]    [Pg.753]    [Pg.753]    [Pg.40]    [Pg.65]    [Pg.178]    [Pg.96]    [Pg.96]    [Pg.776]    [Pg.195]    [Pg.950]    [Pg.127]    [Pg.230]    [Pg.399]    [Pg.201]    [Pg.49]    [Pg.470]    [Pg.176]    [Pg.195]    [Pg.404]    [Pg.764]    [Pg.775]    [Pg.294]    [Pg.3557]    [Pg.63]    [Pg.391]    [Pg.285]    [Pg.244]    [Pg.1024]   


SEARCH



Follow up

© 2024 chempedia.info